GENELUX CORPORATION (GNLX) ROA
- 2026-06-30: ROA -135.84%.
- 2026-03-31: ROA -103.73%.
- 2025-12-31: ROA -168.94%.
- 2025-09-30: ROA -127.56%.
Complete source-backed roa history.
- Available history
- 2022-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -135.84% |
| 2026-03-31 | -103.73% |
| 2025-12-31 | -168.94% |
| 2025-09-30 | -127.56% |
| 2025-06-30 | -94.24% |
| 2025-03-31 | -75.70% |
| 2024-12-31 | -86.04% |
| 2024-09-30 | -68.69% |
| 2024-06-30 | -58.74% |
| 2024-03-31 | -104.49% |
| 2023-12-31 | -101.45% |
| 2023-09-30 | -73.45% |
| 2023-06-30 | -47.10% |
| 2023-03-31 | -80.53% |
| 2022-12-31 | -94.14% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -168.94% |
| 2024-12-31 | -86.04% |
| 2023-12-31 | -101.45% |
| 2022-12-31 | -94.14% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |